Detalles de la búsqueda
1.
North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies.
Blood;
132(14): 1507-1518, 2018 10 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30104217
2.
Broad de-regulated U2AF1 splicing is prognostic and augments leukemic transformation via protein arginine methyltransferase activation.
bioRxiv;
2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38370617
3.
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency.
J Clin Invest;
134(8)2024 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38376944
4.
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: Clinical efficacy and correlative analyses.
Res Sq;
2023 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36865338
5.
Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer.
J Hematol Oncol;
15(1): 70, 2022 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35606824
6.
Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations.
Elife;
112022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36040792
7.
High burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster.
Nat Med;
28(3): 468-471, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35256801
8.
ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine.
Blood Cancer J;
11(9): 157, 2021 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34548471
9.
The thrombopoietin mimetic JNJ-26366821 increases megakaryopoiesis without affecting malignant myeloid proliferation.
Leuk Lymphoma;
61(10): 2453-2465, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32578476
10.
Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks.
Clin Cancer Res;
25(18): 5638-5649, 2019 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31308061
11.
U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies.
Nat Cell Biol;
21(5): 640-650, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31011167
12.
Misidentification of MLL3 and other mutations in cancer due to highly homologous genomic regions.
Leuk Lymphoma;
60(13): 3132-3137, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31288594
13.
Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts.
Elife;
82019 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31663852
14.
Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma.
J Clin Invest;
129(4): 1612-1625, 2019 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30702441
15.
Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells.
J Clin Invest;
128(12): 5479-5488, 2018 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30252677
16.
Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer.
J Hematol Oncol;
15(1): 100, 2022 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35883108
17.
Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia.
Cancer Res;
76(16): 4841-4849, 2016 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27287719
Resultados
1 -
17
de 17
1
Próxima >
>>